- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/215 - Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
Patent holdings for IPC class A61K 31/215
Total number of patents in this class: 1241
10-year publication summary
|
81
|
104
|
105
|
118
|
111
|
84
|
98
|
86
|
69
|
15
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2600 |
22 |
| The Regents of the University of California | 18943 |
17 |
| Infirst Healthcare Limited | 60 |
11 |
| Leo Laboratories Limited | 61 |
11 |
| Mati Therapeutics Inc. | 68 |
11 |
| University of Washington | 2157 |
11 |
| Nabriva Therapeutics GmbH | 25 |
11 |
| Nabriva Therapeutics AG | 27 |
10 |
| Arbor Pharmaceuticals, LLC | 82 |
9 |
| BioCryst Pharmaceuticals, Inc. | 170 |
9 |
| RespiVert Ltd. | 78 |
9 |
| Versitech Limited | 341 |
9 |
| Biosuccess Biotech Co. Ltd. | 24 |
8 |
| CEVA Sante Animale | 683 |
8 |
| Boehringer Ingelheim Animal Health USA Inc. | 507 |
8 |
| Novartis AG | 11238 |
7 |
| F. Hoffmann-La Roche AG | 7958 |
7 |
| Aker Biomarine Human Ingredients AS | 43 |
7 |
| Epicentrx, Inc. | 80 |
6 |
| Romark Laboratories L.C. | 60 |
6 |
| Other owners | 1044 |